rts logo

Pfizer Inc (PFE) Stock Could Soon Reward Patient Investors

Pfizer Inc (NYSE: PFE) is -2.04% lower on its value in year-to-date trading and has touched a low of $24.48 and a high of $31.54 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PFE stock was last observed hovering at around $26.64 in the last trading session, with the day’s loss setting it -0.65%.

Currently trading at $25.99, the stock is -0.36% and -1.23% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 44.8 million and changing -2.44% at the moment leaves the stock -6.29% off its SMA200. PFE registered -2.99% loss for a year compared to 6-month loss of -9.00%.

The stock witnessed a 0.97% gain in the last 1 month and extending the period to 3 months gives it a 1.13%, and is 0.93% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.48% over the week and 2.16% over the month.

Pfizer Inc (PFE) has around 81000 employees, a market worth around $147.29B and $63.63B in sales. Current P/E ratio is 18.46 and Fwd P/E is 8.55. Profit margin for the company is 12.60%. Distance from 52-week low is 6.17% and -17.60% from its 52-week high. The company has generated returns on investments over the last 12 months (5.42%).

with sales reaching $14.43B over the same period.The EPS is expected to shrink by -4.78% this year, but quarterly earnings will post -1.08% year-over-year. Quarterly sales are estimated to shrink -3.04% in year-over-year returns.

Pfizer Inc (PFE) Top Institutional Holders

The shares outstanding are 5.67B, and float is at 5.66B with Short Float at 1.57%.

The top institutional shareholder in the company is VANGUARD GROUP INC with over 511.4 million shares valued at $14.31 billion. The investor’s holdings represent 9.0402% of the PFE Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 424.38 million shares valued at $11.87 billion to account for 7.5018 of the shares outstanding. The other top investors are STATE STREET CORP which holds 287.06 million shares representing 5.0743% and valued at over $8.03 billion, while WELLINGTON MANAGEMENT GROUP LLP holds 2.9401 of the shares totaling 166.32 million with a market value of $4.65 billion.

Pfizer Inc (PFE) Insider Activity

The most recent transaction is an insider sale by DAMICO JENNIFER B., the company’s SVP & Controller. SEC filings show that DAMICO JENNIFER B. sold 2,500 shares of the company’s common stock on Mar 04 ’25 at a price of $25.93 per share for a total of $64825.0. Following the sale, the insider now owns 11850.0 shares.

Pfizer Inc disclosed in a document filed with the SEC on Feb 13 ’25 that BLAYLOCK RONALD E (Director) bought a total of 19,457 shares of the company’s common stock. The trade occurred on Feb 13 ’25 and was made at $25.65 per share for $0.5 million. Following the transaction, the insider now directly holds 27707.0 shares of the PFE stock.

Still, SEC filings show that on Oct 30 ’24, Gottlieb Scott (Director) acquired 1,000 shares at an average price of $28.24 for $28240.0. The insider now directly holds 10,000 shares of Pfizer Inc (PFE).

Related Posts